Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. November 2025 10:22 ET | Quelle: Research and Markets

Pouchitis Market Research and Forecast Report 2025-2035: Takeda, Ocera Therapeutics, Exegi Pharma, and Atlantic Pharmaceuticals Lead Through Innovation, Partnerships, and Product Diversification

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Pouchitis Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
02. Mai 2018 08:00 ET | Quelle: Atlantic Healthcare plc

Atlantic Healthcare completes patient enrollment to its Phase 3 study of alicaforsen to treat IBD Pouchitis

Study completion and top-line data expected in Q1 2019 CAMBRIDGE, U.K., May 02, 2018 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (Atlantic Healthcare), an emerging trans-Atlantic pharmaceutical...
30. Mai 2017 08:00 ET | Quelle: Atlantic Healthcare plc

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

CAMBRIDGE, U.K., May 30, 2017 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI)...
22. Mai 2017 08:00 ET | Quelle: Atlantic Healthcare plc

Atlantic Healthcare announces strengthening of the Board as it prepares for commercialisation of alicaforsen in its first indication

CAMBRIDGE, U.K., May 22, 2017 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI)...